Graham Almond On Sanofi’s Plans to Build Zentiva Generics Brand In Southeast Asia: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
PharmAsia News talks with Sanofi Vice President Southeast Asia, Global Operations Graham Almond to see how the company, with a long-standing presence in the region, is dealing with expansions in public health care coverage to grow its generics business.
You may also be interested in...
Sanofi To Cut Drug Prices In South East Asia In Experiment Aimed At Creating A Sustainable Model Of Access
SHANGHAI - Sanofi-Aventis hopes to widen the availability of its medicines in less developed nations by slashing the price of some drugs in Southeast Asia, in a move that could be modeled after a similar program launched by GlaxoSmithKline one year ago
Sanofi-Aventis Increases Bid For Zentiva To Reach Central, Eastern Europe
Sanofi-Aventis continues pushing to expand with an increased offer for Zentiva, which markets OTC drugs and dietary supplements as well as Rx products in Central and Eastern Europe.
List Ahead For Southeast Asia Pharma In 2015
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.